Last 7 days
5.7%
Last 30 days
12.5%
Last 90 days
27.3%
Trailing 12 Months
-16.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 104.7B | 18.4B | 5.75% | 5.84% | 44.4 | 5.68 | 7.84% | 18.25% |
ISRG | 89.7B | 6.2B | 9.79% | -8.77% | 67.87 | 14.42 | 8.97% | -22.43% |
BSX | 69.0B | 12.7B | 3.45% | 12.48% | 98.9 | 5.44 | 6.68% | -32.95% |
BDX | 68.2B | 19.0B | 0.04% | -5.99% | 42.3 | 3.59 | -0.43% | -8.78% |
EW | 49.1B | 5.4B | 7.07% | -26.22% | 32.28 | 9.13 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 11.64% | 12.09% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.5B | 847.1M | 5.10% | 33.54% | -5.2K | 12.36 | 13.32% | -137.89% |
GMED | 5.3B | 1.0B | -10.58% | -23.27% | 30.73 | 5.18 | 6.76% | 24.45% |
IRTC | 3.7B | 410.9M | 12.45% | -16.48% | -31.51 | 8.91 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 5.14% | -62.54% | -28.72 | 3.39 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
ATEC | 1.7B | 350.9M | 10.32% | 47.03% | -11.09 | 4.81 | 44.26% | -5.42% |
SILK | 1.5B | 138.6M | -27.91% | -1.63% | -26.56 | 10.54 | 36.62% | -10.44% |
AVNS | 1.3B | 820.0M | -1.92% | -12.15% | 26.32 | 1.62 | 10.13% | 701.59% |
CSII | 832.6M | 239.8M | 0.71% | -3.36% | -21.99 | 3.47 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 8.1% | 410,921,000 | 380,108,000 | 361,665,000 | 340,892,000 | 322,825,000 |
Gross Profit | 10.8% | 281,632,000 | 254,208,000 | 239,435,000 | 224,473,000 | 213,567,000 |
Operating Expenses | 4.2% | 395,416,000 | 379,493,000 | 366,916,000 | 345,495,000 | 313,510,000 |
S&GA Expenses | 4.9% | 322,198,000 | 307,080,000 | 297,266,000 | 278,184,000 | 274,839,000 |
R&D Expenses | 1.8% | 46,610,000 | 45,805,000 | 43,042,000 | 40,703,000 | 38,671,000 |
EBITDA | 12.0% | -98,343,000 | -111,816,000 | -115,310,000 | -110,108,000 | - |
EBITDA Margin | 18.6% | -0.24 | -0.29 | -0.32 | -0.32 | - |
Earnings Before Taxes | 9.6% | -115,886,000 | -128,193,000 | -130,495,000 | -123,875,000 | -100,994,000 |
EBT Margin | 16.4% | -0.28 | -0.34 | -0.36 | -0.36 | - |
Interest Expenses | 22.7% | 4,138,000 | 3,373,000 | 3,038,000 | 2,863,000 | 1,169,000 |
Net Income | 9.6% | -116,155,000 | -128,448,000 | -130,728,000 | -124,191,000 | -101,361,000 |
Net Income Margin | 16.4% | -0.28 | -0.34 | -0.36 | -0.36 | - |
Free Cahsflow | 30.5% | -52,842,000 | -75,995,000 | -68,962,000 | -64,224,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 1.8% | 448 | 440 | 436 | 429 | 463 |
Current Assets | 1.0% | 289 | 286 | 285 | 286 | 306 |
Cash Equivalents | 10.7% | 79.00 | 71.00 | 101 | 95.00 | 128 |
Inventory | 4.9% | 15.00 | 14.00 | 14.00 | 12.00 | 10.00 |
Net PPE | 5.8% | 76.00 | 72.00 | 66.00 | 57.00 | 56.00 |
Goodwill | 0% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 3.6% | 208 | 201 | 191 | 184 | 183 |
Current Liabilities | 6.6% | 89.00 | 84.00 | 70.00 | 62.00 | 88.00 |
Long Term Debt | - | 10.00 | - | - | - | - |
LT Debt, Non Current | 0.0% | 35.00 | 35.00 | 35.00 | 35.00 | 10.00 |
Shareholder's Equity | 0.2% | 240 | 239 | 245 | 245 | 280 |
Retained Earnings | -4.0% | -522 | -502 | -480 | -456 | -406 |
Additional Paid-In Capital | 2.8% | 762 | 742 | 726 | 702 | 686 |
Accumulated Depreciation | 9.6% | 32.00 | 29.00 | 26.00 | 23.00 | - |
Shares Outstanding | 0.3% | 30.00 | 30.00 | 30.00 | 30.00 | 29.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 52.7% | -23.01 | -48.63 | -34.62 | -34.80 | -37.75 |
Share Based Compensation | 7.3% | 58.00 | 54.00 | 53.00 | 48.00 | 55.00 |
Cashflow From Investing | 26.6% | -52.43 | -71.45 | -22.43 | -20.30 | 105 |
Cashflow From Financing | 11.6% | 27.00 | 24.00 | 19.00 | 13.00 | -28.58 |
89.6%
71.9%
30.4%
Y-axis is the maximum loss one would have experienced if Irhythm Tech was unfortunately bought at previous high price.
14.4%
14.6%
FIve years rolling returns for Irhythm Tech.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 20.42 | -77,062 | 694,938 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -1.91 | -68,000 | 187,000 | -% |
2023-02-28 | Voya Investment Management LLC | unchanged | - | -363,137 | 1,074,860 | -% |
2023-02-21 | Empowered Funds, LLC | sold off | -100 | -1,679,000 | - | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -0.07 | -584,000 | 1,578,000 | -% |
2023-02-17 | TRUIST FINANCIAL CORP | reduced | -2.89 | -709,324 | 1,879,680 | -% |
2023-02-17 | Ascent Group, LLC | unchanged | - | -90,496 | 251,504 | 0.03% |
2023-02-16 | IMA Wealth, Inc. | unchanged | - | -171,182 | 505,818 | 0.13% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | reduced | -52.38 | -1,063 | 937 | -% |
2023-02-15 | HOWE & RUSLING INC | sold off | -100 | -38,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | sands capital management, llc | 9.1% | 2,667,428 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.55% | 2,876,849 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.6% | 2,288,507 | SC 13G/A | |
Jan 27, 2023 | mackenzie financial corp | 4.14% | 1,246,524 | SC 13G/A | |
Feb 14, 2022 | sands capital management, llc | 10.34% | 3,041,867 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 1.7% | 524,505 | SC 13G/A | |
Feb 04, 2022 | mackenzie financial corp | 5.73% | 1,685,430 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.1% | 2,084,707 | SC 13G/A | |
Jan 24, 2022 | jpmorgan chase & co | 7.0% | 2,083,625 | SC 13G | |
Jul 09, 2021 | brown capital management llc | 0% | 0 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 4.01 -96.69% | 6.61 -94.55% | 14.47 -88.06% | 29.61 -75.57% | 60.33 -50.23% |
Current Inflation | 3.82 -96.85% | 6.12 -94.95% | 12.93 -89.33% | 25.86 -78.67% | 51.96 -57.13% |
Very High Inflation | 3.57 -97.05% | 5.53 -95.44% | 11.12 -90.83% | 21.51 -82.25% | 42.34 -65.07% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 15, 2023 | 8-K | Current Report | |
Mar 10, 2023 | 8-K | Current Report | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | Devine Douglas | sold | -172,680 | 117 | -1,473 | chief operating officer |
2023-03-03 | Murphy Patrick Michael | sold | -66,938 | 117 | -571 | clo & evp ra/qa mrktacs & gov |
2023-03-03 | Wilson Daniel G. | sold | -166,701 | 117 | -1,422 | evp, strategy corp dev inv rel |
2023-03-03 | Day Mark J. | sold | -248,059 | 117 | -2,116 | chief technology officer |
2023-02-28 | Wilson Daniel G. | sold | -203,395 | 117 | -1,726 | evp, strategy corp dev inv rel |
2023-02-28 | Day Mark J. | sold | -225,431 | 117 | -1,913 | chief technology officer |
2023-02-28 | Devine Douglas | sold | -414,563 | 117 | -3,518 | chief operating officer |
2023-02-27 | Shrishrimal Sumi | acquired | - | - | 6,961 | evp, chief risk officer |
2023-02-27 | Bobzien Brice | acquired | - | - | 9,282 | chief financial officer |
2023-02-27 | Day Mark J. | acquired | - | - | 11,822 | chief technology officer |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue, net | $ 410,921 | $ 322,825 | $ 265,166 |
Cost of revenue | 129,289 | 109,258 | 70,277 |
Gross profit | 281,632 | 213,567 | 194,889 |
Operating expenses: | |||
Research and development | 46,610 | 38,671 | 41,329 |
Selling, general and administrative | 322,198 | 274,839 | 197,233 |
Impairment and restructuring charges | 26,608 | 0 | 0 |
Total operating expenses | 395,416 | 313,510 | 238,562 |
Loss from operations | (113,784) | (99,943) | (43,673) |
Interest expense | (4,138) | (1,169) | (1,519) |
Other income (expense), net | 2,036 | 118 | 1,591 |
Loss before income taxes | (115,886) | (100,994) | (43,601) |
Income tax provision | 269 | 367 | 229 |
Net loss | $ (116,155) | $ (101,361) | $ (43,830) |
Net loss per common share, basic (in USD per share) | $ (3.88) | $ (3.46) | $ (1.58) |
Net loss per common share, diluted (in USD per share) | $ (3.88) | $ (3.46) | $ (1.58) |
Weighted-average shares, basic (in shares) | 29,915,720 | 29,331,010 | 27,754,404 |
Weighted-average shares, diluted (in shares) | 29,915,720 | 29,331,010 | 27,754,404 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 78,832 | $ 127,562 |
Short-term investments | 134,312 | 111,569 |
Accounts receivable, net | 49,918 | 46,430 |
Inventory | 15,155 | 10,268 |
Prepaid expenses and other current assets | 10,555 | 9,693 |
Total current assets | 288,772 | 305,522 |
Property and equipment, net | 75,670 | 55,944 |
Operating lease right-of-use assets | 60,666 | 84,587 |
Goodwill | 862 | 862 |
Other assets | 22,252 | 16,052 |
Total assets | 448,222 | 462,967 |
Current liabilities: | ||
Accounts payable | 7,517 | 10,509 |
Accrued liabilities | 65,497 | 51,486 |
Deferred revenue | 3,051 | 3,049 |
Debt, current | 0 | 11,667 |
Operating lease liabilities, current | 13,031 | 11,142 |
Total current liabilities | 89,096 | 87,853 |
Debt, noncurrent | 34,935 | 9,690 |
Other noncurrent liabilities | 1,307 | 697 |
Operating lease liabilities, noncurrent | 83,072 | 85,212 |
Total liabilities | 208,410 | 183,452 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value – 5,000,000 shares authorized at December 31, 2022 and 2021; and none issued and outstanding at December 31, 2022 and 2021, respectively | 0 | 0 |
Common stock, $0.001 par value – 100,000,000 shares authorized at December 31, 2022 and 2021; 30,193,101 and 29,493,726 shares issued and outstanding at December 31, 2022 and 2021, respectively | 28 | 27 |
Additional paid-in capital | 762,380 | 685,594 |
Accumulated other comprehensive income (loss) | (396) | (61) |
Accumulated deficit | (522,200) | (406,045) |
Total stockholders’ equity | 239,812 | 279,515 |
Total liabilities and stockholders’ equity | $ 448,222 | $ 462,967 |